OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference

Health and Fitness Health and Fitness

Thu, November 15, 2012

[ Thu, Nov 15th 2012 ] - Market Wire

Beijing PLA General Hospital treats more than 1,0 .. urosurgery patients using VISIUS Surgical Theatre

[ Thu, Nov 15th 2012 ] - Market Wire

MiMedx Group to Present at the New York Society o .. th Annual "Investing in Life Sciences" Conference

[ Thu, Nov 15th 2012 ] - Market Wire

Dr. Jeff Jonas Appointed President of Shire Regen .. Medicine Business and Joins Shire Leadership Team

[ Thu, Nov 15th 2012 ] - Market Wire

Rosetta Genomics Added to Ocean Tomo 300 Patent Index

[ Thu, Nov 15th 2012 ] - Market Wire

Gilead Sciences, Silver Wheaton, Marvell, Dollar Tree, F5 Networks, and American Capital

[ Thu, Nov 15th 2012 ] - Market Wire

Pressure BioSciences, Inc. Reports Record PCT Product Sales in Q3 2012

[ Thu, Nov 15th 2012 ] - Market Wire

Maricopa Integrated Health System Installs Masimo .. a" System for Improved Oversight of General Floor

[ Thu, Nov 15th 2012 ] - Market Wire

Turning complex hip revisions into efficient, rep .. new REDAPTa" Revision Femoral System from Smith a

[ Thu, Nov 15th 2012 ] - Market Wire

Insulet Ranked Among the Fastest Growing Companie .. merica on Deloitte's 2012 Technology Fast 500(TM)

[ Thu, Nov 15th 2012 ] - Market Wire

Threshold Pharmaceuticals Reports Updated Phase 2 .. f Maintenance Therapy With TH-302 Following Induc

[ Thu, Nov 15th 2012 ] - Market Wire

AtheroNova Receives Notice of Issuance of Its U.S. Patent 8,304,383

[ Thu, Nov 15th 2012 ] - Market Wire

GPR17-Targeting Compounds Identified by Omeros Promote Myelination

[ Thu, Nov 15th 2012 ] - Market Wire

Solta Medical Appoints Lisa Parr as Vice President of Regulatory Affairs and Clinical Affairs

[ Thu, Nov 15th 2012 ] - Market Wire

EnteroMedics to Present at the Piper Jaffray 24th Annual Healthcare Conference

[ Thu, Nov 15th 2012 ] - Market Wire

Given Imaging Announces Participation at the JP Morgan SMid Cap Conference on November 29, 2012

[ Thu, Nov 15th 2012 ] - Market Wire

Fonar Reports First Quarter Financial Results; .. ight Quarter of Net Income Exceeding $1.5 Million

[ Thu, Nov 15th 2012 ] - Market Wire

OncoSec Medical Reports Positive Preliminary Effi .. udy of ImmunoPulse in Metastatic Melanoma Patient

Wed, November 14, 2012

[ Wed, Nov 14th 2012 ] - Market Wire

Ceapro Signs Another Partnership With Agriculture .. for the Commercial Development of its Flagship Pr

[ Wed, Nov 14th 2012 ] - Market Wire

biOasis Enters Into a Research &;; Evaluation Agreement with MedImmune

[ Wed, Nov 14th 2012 ] - Market Wire

Unilens Vision Reports First Quarter Operating Results

[ Wed, Nov 14th 2012 ] - Market Wire

FDA on Pace to Approve More New Drugs in 2012 Than the 30 Approved in 2011

[ Wed, Nov 14th 2012 ] - Market Wire

Improving Trend in FDA First Cycle Review Approva .. jor Factor for Biotech Industry's Success in 2012

[ Wed, Nov 14th 2012 ] - Market Wire

Boston Therapeutics' Newly Appointed Chief Operat .. $625,000 in the Company's S-1 Financial Offering

[ Wed, Nov 14th 2012 ] - Market Wire

USANA And ConsumerLab.com See Eye To Eye On Visionex

[ Wed, Nov 14th 2012 ] - Market Wire

Promising Data Presented on GenVec Malaria Program

[ Wed, Nov 14th 2012 ] - Market Wire

ProPhase Labs Reports Financial Results for the Three and Nine Months Ended September 30, 2012

[ Wed, Nov 14th 2012 ] - Market Wire

Discovery Labs Appoints John R. Leone to Board of Directors

[ Wed, Nov 14th 2012 ] - Market Wire

Alimera Sciences Names European Management Team

[ Wed, Nov 14th 2012 ] - Market Wire

EntreMed Reports Third Quarter 2012 Financial Results

[ Wed, Nov 14th 2012 ] - Market Wire

NewLink Genetics Receives European Orphan Designa .. ntucel-L Immunotherapy to Treat Pancreatic Cancer

[ Wed, Nov 14th 2012 ] - Market Wire

Biota Pharmaceuticals Announces Appointment of New Executive Officers

[ Wed, Nov 14th 2012 ] - Market Wire

Japan's Nuclear Power Plants Continue to Purchase Implant Sciences' Explosives Trace Detectors

[ Wed, Nov 14th 2012 ] - Market Wire

OncoSec Medical Reports Positive Interim Efficacy .. hase IV Study of NeoPulse in Skin Cancer Patients

[ Wed, Nov 14th 2012 ] - Market Wire

Comprehensive Care Corporation Announces Profitable Nine Month Financial Results

Tue, November 13, 2012

[ Tue, Nov 13th 2012 ] - Market Wire

Sirona Biochem Announces Stock Options Exercise Price Revision

[ Tue, Nov 13th 2012 ] - Market Wire

Atrion Corporation Declares Special Cash Dividend of $10.00 Per Share

[ Tue, Nov 13th 2012 ] - Market Wire

Lilly and Incyte Announce Additional Phase IIb Ba .. RI Results, in Patients with Rheumatoid Arthritis

[ Tue, Nov 13th 2012 ] - Market Wire

Perrigo Confirms Settlement Of Generic Version Of .. dote (acetylcysteine) Injection Patent Litigation

[ Tue, Nov 13th 2012 ] - Market Wire

Abbott Announces Phase 3 Hepatitis C Program Details

[ Tue, Nov 13th 2012 ] - Market Wire

Skystar's New Vaccine Facility in Huxian Passes Initial GMP Certification

[ Tue, Nov 13th 2012 ] - Market Wire

CareFusion Launches New Preoperative Cleansing Program For In-Home Patient Use

[ Tue, Nov 13th 2012 ] - Market Wire

Titan Medical Inc. to Present at the 24th Annual Piper Jaffray Healthcare Conference

[ Tue, Nov 13th 2012 ] - Market Wire

Abbott Announces Results for Any and All Debt Tender Offers

[ Tue, Nov 13th 2012 ] - Market Wire

Graphite Corp. Commences Resource Field Study in Alabama

[ Tue, Nov 13th 2012 ] - Market Wire

International Stem Cell Corp Subsidiary Lifeline Skin Care Announces Latest Product Launch

[ Tue, Nov 13th 2012 ] - Market Wire

VistaGen Therapeutics Enhances Predictive Liver T .. ug Metabolism Bioassay System -- LiverSafe 3D(TM)

[ Tue, Nov 13th 2012 ] - Market Wire

Boston Therapeutics Names Jonathan B.Rome Chief Operating Officer

[ Tue, Nov 13th 2012 ] - Market Wire

ViroPharma's Cinryze (C1 Esterase Inhibitor [Huma .. Safety Data of Escalating Doses in Patients With

[ Tue, Nov 13th 2012 ] - Market Wire

Omeros is Not Aware of Any Justification for Share Price Movement

[ Tue, Nov 13th 2012 ] - Market Wire

Implant Sciences Sells Follow-On Order to the Secret Service Organization of an Asian Nation

[ Tue, Nov 13th 2012 ] - Market Wire

Adherex Reports Positive Developments and Third Quarter September 30, 2012 Financial Results

Mon, November 12, 2012

[ Mon, Nov 12th 2012 ] - Market Wire

Medifocus Inc. Announces Extension of Warrants

[ Mon, Nov 12th 2012 ] - Market Wire

CooperVision Renews Its Support of U.S. Military Personnel

[ Mon, Nov 12th 2012 ] - Market Wire

AdCare Health Systems Inc. Investor Presentation .. n-demand Viewing at RetailInvestorConferences.com

[ Mon, Nov 12th 2012 ] - Market Wire

Biotech Industry Skyrockets in 2012 as FDA Approval Rate Increases

[ Mon, Nov 12th 2012 ] - Market Wire

350+ USANA-Sponsored Athletes Prep For Winter Sport Season

[ Mon, Nov 12th 2012 ] - Market Wire

MethylGene Announces Cdn.$26.1 Million Private Placement

[ Mon, Nov 12th 2012 ] - Market Wire

Insmed To Present At Two Upcoming Investor Conferences

[ Mon, Nov 12th 2012 ] - Market Wire

Trinity Medical Center Adds Masimo Patient Safety .. gh Vigilance Safeguard for Post-Surgical Patients

[ Mon, Nov 12th 2012 ] - Market Wire

Milestone Scientific Reports Third Quarter Financial Results and Provides Business Update

[ Mon, Nov 12th 2012 ] - Market Wire

Aeterna Zentaris Announces Initiation of Phase 2 .. Phase 1/2 Trial with AEZS-108 in Prostate Cancer

[ Mon, Nov 12th 2012 ] - Market Wire

Implant Sciences Wins Defense Contract in Middle East

[ Mon, Nov 12th 2012 ] - Market Wire

VentriPoint Expands European Network of Expert Us .. rdiac Centres in Austria, Netherlands and Germany

[ Mon, Nov 12th 2012 ] - Market Wire

Oncolytics Biotech Inc. Announces Addition to Senior Management Team

[ Mon, Nov 12th 2012 ] - Market Wire

AstraZeneca Announces Top-line Phase III Results .. ials In Patients With Opioid-Induced Constipation

[ Mon, Nov 12th 2012 ] - Market Wire

SciClone to Present at Lazard Capital Markets 9th Annual Healthcare Conference on November 14th

[ Mon, Nov 12th 2012 ] - Market Wire

Cynosure, Inc. Announces Proposed Public Offering of Class A Common Stock

[ Mon, Nov 12th 2012 ] - Market Wire

China Cord Blood Corporation Announces Completion .. Strategic Partnership with Cordlife Group Limited

Sun, November 11, 2012

[ Sun, Nov 11th 2012 ] - Market Wire

Nektar To Host Conference Call To Discuss The Positive Phase 3 Clinical Results For Naloxegol

[ Sun, Nov 11th 2012 ] - Market Wire

Galapagos receives positive ruling on Patent Income Deduction

[ Sun, Nov 11th 2012 ] - Market Wire

Apexigen Announces Initiation of Clinical Trials By Its Partner, Simcere Pharmaceutical Group

[ Sun, Nov 11th 2012 ] - Market Wire

NuVasive Announces Change of Venue for Investor Event -- Now at the W Hotel at Union Square Park

[ Sun, Nov 11th 2012 ] - Market Wire

Horizon Pharma Presents Clinical Data Demonstrati .. yed-Release Tablets Reduce Fatigue in Patients Wi

[ Sun, Nov 11th 2012 ] - Market Wire

GLPG0634 single center Proof of Concept results t .. t American College of Rheumatology Annual meeting

Sat, November 10, 2012

[ Sat, Nov 10th 2012 ] - Market Wire

Gilead kndigt eine zu 100Prozent anhaltende virol .. r interferonfreie Behandlung mit Sofosbuvir (GS-7

[ Sat, Nov 10th 2012 ] - Market Wire

Gilead kndigt eine zu 100Prozent anhaltende virol .. r interferonfreie Behandlung mit Sofosbuvir (GS-7

[ Sat, Nov 10th 2012 ] - Market Wire

Gilead kndigt eine zu 100Prozent anhaltende virol .. r interferonfreie Behandlung mit Sofosbuvir (GS-7

[ Sat, Nov 10th 2012 ] - Market Wire

Gilead kndigt eine zu 100Prozent anhaltende virol .. r interferonfreie Behandlung mit Sofosbuvir (GS-7

[ Sat, Nov 10th 2012 ] - Market Wire

Gilead kndigt eine zu 100Prozent anhaltende virol .. r interferonfreie Behandlung mit Sofosbuvir (GS-7

[ Sat, Nov 10th 2012 ] - Market Wire

Vertex prsente de nouveaux rsultats de phase 3 qu .. atteints dahpatite C ayant reu un traitement de 2

[ Sat, Nov 10th 2012 ] - Market Wire

Gilead annuncia un tasso di risposta virologica s .. VR4) per un regime senza interferone a base di so

[ Sat, Nov 10th 2012 ] - Market Wire

Gilead annuncia un tasso di risposta virologica s .. VR4) per un regime senza interferone a base di so

Fri, November 9, 2012

[ Fri, Nov 09th 2012 ] - Market Wire

Les donnes issues d';;;;;& .. de cintique virale ont dmontr la rduction rapide

[ Fri, Nov 09th 2012 ] - Market Wire

Data from Viral Kinetic Study Showed Rapid Reduct .. (VX-135),;;;;;;;;;&

[ Fri, Nov 09th 2012 ] - Market Wire

Quest Diagnostics Confirms Investor Day on November 16

[ Fri, Nov 09th 2012 ] - Market Wire

Hansen Medical's Magellan(TM) Robotic System to B .. ITHsymposium(TM) of Vascular Surgeons and Interve

[ Fri, Nov 09th 2012 ] - Market Wire

Hansen Medical to Present at 9th Annual Lazard Capital Markets Healthcare Conference

[ Fri, Nov 09th 2012 ] - Market Wire

Abbott Announces Early Tender Results for Partial .. Offers and Extends Any and All Debt Tender Offers

[ Fri, Nov 09th 2012 ] - Market Wire

Health Care Executive, Scholar and Vice Chancello .. shington, Appointed to Johnson amp;; Johns

[ Fri, Nov 09th 2012 ] - Market Wire

Jean Mixer Joins NxStage Board of Directors

[ Fri, Nov 09th 2012 ] - Market Wire

Celsion Announces Phase III HEAT Study of ThermoD .. er Reaches Target Number of Events for Unblinding

[ Fri, Nov 09th 2012 ] - Market Wire

Echo Therapeutics Chosen to Present at the 12th Annual Diabetes Technology Meeting

[ Fri, Nov 09th 2012 ] - Market Wire

Omeros Responds to Misleading Announcement by Dav .. ng Settlement with Former Chief Financial Officer

[ Fri, Nov 09th 2012 ] - Market Wire

HeartWare Reports Third Quarter 2012 Results

[ Fri, Nov 09th 2012 ] - Market Wire

Novel Cancer Immune Therapy Developer Oncos Thera .. Industry Leader Frans Wuite as President and CEO

[ Fri, Nov 09th 2012 ] - Market Wire

Oncolytics Biotech Inc. Collaborators Present Pos .. Results and Research at EORTC-NCI-AACR Symposium

[ Fri, Nov 09th 2012 ] - Market Wire

IRIDEX Signs Global Licensing Agreement with QUANTEL Medical

[ Fri, Nov 09th 2012 ] - Market Wire

OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference

Thu, November 8, 2012

[ Thu, Nov 08th 2012 ] - Market Wire

Unilife's Bolus Injector Platform Targeted by Glo .. rmaceutical Company for Use in Multi-Drug Program

[ Thu, Nov 08th 2012 ] - Market Wire

Verisante Technology, Inc. Issues Operational Upd .. inics Across Canada, Distribution Sales Force Bei

[ Thu, Nov 08th 2012 ] - Market Wire

Sanofi Pasteur Announces Publication of Pivotal S .. Data of Menactra Vaccine for Infants and Toddlers

[ Thu, Nov 08th 2012 ] - Market Wire

Northstar announces breakthrough new product line .. o target the $2.7 billion sports nutrition market

[ Thu, Nov 08th 2012 ] - Market Wire

Sunrise Senior Living Announces Executive Transitions

[ Thu, Nov 08th 2012 ] - Market Wire

Stem Cell Stocks Gaining Popularity in 2012 as a Result of Breakthroughs in Research

[ Thu, Nov 08th 2012 ] - Market Wire

Enzon Announces Two Oral Presentations at the Symposium of Drug Delivery Systems in Nanjing, China

[ Thu, Nov 08th 2012 ] - Market Wire

Cardica To Present At Lazard Capital Markets 9th Annual Healthcare Conference

[ Thu, Nov 08th 2012 ] - Market Wire

Discovery Labs Reports Third Quarter 2012 Financial Results

[ Thu, Nov 08th 2012 ] - Market Wire

Rigel to Present at Jefferies 2012 Global Healthcare Conference in London

[ Thu, Nov 08th 2012 ] - Market Wire

Aeterna Zentaris Presents Proof-of-Concept for Di .. s, such as AEZS-125, in Ovarian Cancer Mouse Mode

[ Thu, Nov 08th 2012 ] - Market Wire

JAMA Study Demonstrates Efficacy of Life Technolo .. ecting Early Metastases, Supports Screening for L

[ Thu, Nov 08th 2012 ] - Market Wire

Milestone Scientific and Aseptico Form Strategic Alliance

[ Thu, Nov 08th 2012 ] - Market Wire

Cornerstone Therapeutics Acquires Exclusive U.S. .. S.p.A.'s BETHKIS(R) (Tobramycin Inhalation Solut

[ Thu, Nov 08th 2012 ] - Market Wire

Omeros to Present Data from Successful OMS302 Pha .. American Academy of Ophthalmology Annual Meeting

[ Thu, Nov 08th 2012 ] - Market Wire

MethylGene Presents MGCD265 Data at the 24th EORT .. sium on Molecular Targets and Cancer Therapeutics

Wed, November 7, 2012

[ Wed, Nov 07th 2012 ] - Market Wire

Edwards Lifesciences to Present at the Credit Suisse 2012 Healthcare Conference

[ Wed, Nov 07th 2012 ] - Market Wire

Cantel Medical Appoints Jorgen B. Hansen As Executive Vice President And Chief Operating Officer

[ Wed, Nov 07th 2012 ] - Market Wire

BIOLASE to Present at Lazard Capital Markets 9th Annual Healthcare Conference

[ Wed, Nov 07th 2012 ] - Market Wire

VELscope Reaches 25 Million Oral Cancer Exams Milestone

[ Wed, Nov 07th 2012 ] - Market Wire

Johnson amp;; Johnson to Participate in Credit Suisse 2012 Healthcare Conference

[ Wed, Nov 07th 2012 ] - Market Wire

VIVUS, Micron, Oracle, Hewlett-Packard, AOL, and MIPS Technologies

[ Wed, Nov 07th 2012 ] - Market Wire

VistaGen Therapeutics and Duke University Announc .. ogress at American Heart Association 2012 Scienti

[ Wed, Nov 07th 2012 ] - Market Wire

Graphite Corp. Increases Land Position to 1700 Acres in Montana

[ Wed, Nov 07th 2012 ] - Market Wire

ImmuCell Announces Product Sales Increases and Other Financial Results

[ Wed, Nov 07th 2012 ] - Market Wire

Zynex Schedules Third Quarter 2012 Earnings Release and Webcast

[ Wed, Nov 07th 2012 ] - Market Wire

Threshold Pharmaceuticals Announces Presentation .. Capital Markets 9th Annual Healthcare Conference

[ Wed, Nov 07th 2012 ] - Market Wire

Aeterna Zentaris to Announce Third Quarter 2012 F .. ancial and Operating Results on November 13, 2012

[ Wed, Nov 07th 2012 ] - Market Wire

Syneron Medical Appoints Jonathan Pearson as Exec .. esident of Business Development, Topical Products

[ Wed, Nov 07th 2012 ] - Market Wire

IRIDEX Announces Tender Offer to Purchase up to 487,500 Shares of its Common Stock

[ Wed, Nov 07th 2012 ] - Market Wire

Isis Pharmaceuticals To Present At The Lazard Capital Markets 9th Annual Healthcare Conference

[ Wed, Nov 07th 2012 ] - Market Wire

Misonix Reports Strong Revenue Increases for the First Quarter of Fiscal 2013

Tue, November 6, 2012

[ Tue, Nov 06th 2012 ] - Market Wire

Uroplasty To Participate In Two Upcoming Investor Conferences

[ Tue, Nov 06th 2012 ] - Market Wire

Sunrise Senior Living Applauds Utility Companies Following Hurricane Sandy

[ Tue, Nov 06th 2012 ] - Market Wire

CooperSurgical Launches The Reengineered Carter-Thomason II Port Closure System

[ Tue, Nov 06th 2012 ] - Market Wire

LX4211 Phase 2b Results Presented At American Heart Association Annual Conference

[ Tue, Nov 06th 2012 ] - Market Wire

Syneron presenta i suoi innovativi prodotti per l .. ollaborazione con la BODY Conference and Exhibiti

[ Tue, Nov 06th 2012 ] - Market Wire

Vista Partners Updates Coverage on ADVENTRX Pharm .. icals, Inc.;; Raises Target Price to $4.50

[ Tue, Nov 06th 2012 ] - Market Wire

Timing Is Crucial, Upside Analysis of Election Re .. on Johnson &;; Johnson and Davita Inc.

[ Tue, Nov 06th 2012 ] - Market Wire

00 a.m. ET on Friday, November 9, 2012

[ Tue, Nov 06th 2012 ] - Market Wire

Sarepta Therapeutics to Present Company Overview .. Capital Markets 9th Annual Healthcare Conference

[ Tue, Nov 06th 2012 ] - Market Wire

Celsion to Present at the Lazard Capital Markets 9th Annual Healthcare Conference

[ Tue, Nov 06th 2012 ] - Market Wire

Rigel Announces Third Quarter 2012 Financial Results

[ Tue, Nov 06th 2012 ] - Market Wire

Implant Sciences QS-B220 Explosives and Drugs Tra .. in Government Security News Homeland Security Aw

[ Tue, Nov 06th 2012 ] - Market Wire

Response Genetics, Inc. to Release Third Quarter .. lts and Host Conference Call on November 13, 2012

[ Tue, Nov 06th 2012 ] - Market Wire

ShangPharma to Report Third Quarter 2012 Financial Results on November 20, 2012

[ Tue, Nov 06th 2012 ] - Market Wire

Lexicon Pharmaceuticals Reports on Clinical Program Status and 2012 Third Quarter Results

[ Tue, Nov 06th 2012 ] - Market Wire

Concord Medical to Report Third Quarter 2012 Financial Results on November 21, 2012

Mon, November 5, 2012

[ Mon, Nov 05th 2012 ] - Market Wire

Cardica Announces Fiscal 2013 First Quarter Financial Results

[ Mon, Nov 05th 2012 ] - Market Wire

Six New Plaintiffs Join Sanford Heisler's $100m G .. tion Against Forest Laboratories & Forest Pharmac

[ Mon, Nov 05th 2012 ] - Market Wire

Results from the Largest Known Cholesterol Survey .. ced at the American Heart Association's Annual Sc

[ Mon, Nov 05th 2012 ] - Market Wire

PharmAthene To Host Third Quarter 2012 Conference Call And Webcast On Tuesday, November 6, 2012

[ Mon, Nov 05th 2012 ] - Market Wire

Medisafe 1 Technologies Announces Delay in Closin .. 7MM Perpetual License Sale Due to Hurricane Sandy

[ Mon, Nov 05th 2012 ] - Market Wire

CTLM(R) 3D Laser Breast Imaging System Sold and Shipped to Romania

[ Mon, Nov 05th 2012 ] - Market Wire

Array BioPharma To Present Clinical Data At The 2 .. A KSP Inhibitor, And ARRY-614, A Dual p38/Tie2 In

[ Mon, Nov 05th 2012 ] - Market Wire

Medicure Announces Agreement to Promote Aggrastat(R) in the Commonwealth of Puerto Rico

[ Mon, Nov 05th 2012 ] - Market Wire

NuVasive Announces Change of Date for Investor Event -- Now to Be Held on November 14, 2012

[ Mon, Nov 05th 2012 ] - Market Wire

Syneron Destaca sus Productos innovadores en lipo .. in con la Conferencia y Exposicin BODY en Londres

[ Mon, Nov 05th 2012 ] - Market Wire

Life Technologies Acquires Advanced Microscopy Group

[ Mon, Nov 05th 2012 ] - Market Wire

AcelRx Pharmaceuticals Doses the First Patients in ARX-04 Phase 2 Clinical Study

[ Mon, Nov 05th 2012 ] - Market Wire

Horizon Pharma Announces Clinical Data on RAYOS(R .. e Tablets to Be Presented at the American College

[ Mon, Nov 05th 2012 ] - Market Wire

Record First Quarter for Greystone Logistics

[ Mon, Nov 05th 2012 ] - Market Wire

VolitionRx's Preliminary Diagnostic Clinical Tria .. ty and Specificity for Colon, Breast and Lung Can

[ Mon, Nov 05th 2012 ] - Market Wire

Response Genetics, Inc. to Offer ROS1 Testing for Lung Cancer

Sat, November 3, 2012

[ Sat, Nov 03rd 2012 ] - Market Wire

Phase 3 Sensipar/Mimpara EVOLVEa" Trial Published In The New England Journal Of Medicine

Fri, November 2, 2012

[ Fri, Nov 02nd 2012 ] - Market Wire

Lpath Announces Filing of Shelf Registration Statement

[ Fri, Nov 02nd 2012 ] - Market Wire

Hypertensive Acute Heart Failure Study Results to .. erican Heart Association Scientific Sessions 2012

[ Fri, Nov 02nd 2012 ] - Market Wire

Bernstein Liebhard LLP Announces Investigation Into Abiomed, Inc.

[ Fri, Nov 02nd 2012 ] - Market Wire

Medivation Announces Third Quarter 2012 Financial Results Teleconference on November 9, 2012

[ Fri, Nov 02nd 2012 ] - Market Wire

China Biologic Products to Report Third Quarter 2012 Financial Results

[ Fri, Nov 02nd 2012 ] - Market Wire

Centene Corporation Announces Pricing Of Notes

[ Fri, Nov 02nd 2012 ] - Market Wire

Block amp;; Leviton LLP Investigates Abiom .. ficers and Directors for Possible Violations of t

[ Fri, Nov 02nd 2012 ] - Market Wire

Hill-Rom to Participate in the Credit Suisse 2012 Healthcare Conference

[ Fri, Nov 02nd 2012 ] - Market Wire

Amgen To Present Data From Four Phase 2 Studies A .. erican Heart Association Scientific Sessions 2012

[ Fri, Nov 02nd 2012 ] - Market Wire

Abbott and the Abbott Fund Donate $1 Million in F .. roducts to Support Hurricane Sandy Relief Efforts

[ Fri, Nov 02nd 2012 ] - Market Wire

HealthTronics Launches New Line Of Slimline Cryoprobes For Use With Its Endocare Cryocare Systems

[ Fri, Nov 02nd 2012 ] - Market Wire

Analyst Opinion on Health Management Associates I .. . -- Hospitals Post Mixed Quarterly Results, Lowe

[ Fri, Nov 02nd 2012 ] - Market Wire

Analyst Opinion on Universal Health Services Inc. .. s Inc. -- Hospitals Post Mixed Quarterly Results,

[ Fri, Nov 02nd 2012 ] - Market Wire

Celsion Corporation to Hold Third Quarter 2012 Fi .. ults Conference Call on Monday, November 12, 2012

[ Fri, Nov 02nd 2012 ] - Market Wire

Implant Sciences Awarded Contract to Deploy Explo .. t Nigerian Corporation to Protect Against Terrori

[ Fri, Nov 02nd 2012 ] - Market Wire

Titan Medical Inc. Announces Memorandum of Understanding With The University of Florida

Thu, November 1, 2012

[ Thu, Nov 01st 2012 ] - Market Wire

Cornerstone Therapeutics to Host Third Quarter 2012 Conference Call

[ Thu, Nov 01st 2012 ] - Market Wire

HealthSouth to Present at Investor Conferences in November

[ Thu, Nov 01st 2012 ] - Market Wire

Halozyme to Host Third Quarter Financial Results Conference Call

[ Thu, Nov 01st 2012 ] - Market Wire

Medicure Completes Share Consolidation

[ Thu, Nov 01st 2012 ] - Market Wire

ProMetic Presenting Positive New Anti-Fibrotic Da .. Society of Nephrology Annual Meeting in San Diego

[ Thu, Nov 01st 2012 ] - Market Wire

CombiMatrix Corporation Selects Cartagenia BENCHl .. b CNV Platform to Bolster Expanded Lab Operations

[ Thu, Nov 01st 2012 ] - Market Wire

Financial Review on Healthcare Stocks Teva Pharma .. Allergan Inc. -- Drug Manufacturers Focusing on E

[ Thu, Nov 01st 2012 ] - Market Wire

BioTech Medics, Inc. Signs Letter of Interest Wit .. or $5 Million Cross-Marketing Licensing Agreement

[ Thu, Nov 01st 2012 ] - Market Wire

Hansen Medical Announces Third Quarter 2012 Results Conference Call

[ Thu, Nov 01st 2012 ] - Market Wire

Cornerstone Therapeutics Receives Complete Response Letter From the FDA for Lixivaptan

[ Thu, Nov 01st 2012 ] - Market Wire

Life Technologies Collaborates with USDA to Devel .. p Same-Day, Multi-Strain E. coli Detection System

[ Thu, Nov 01st 2012 ] - Market Wire

Accuray Receives FDA 510(k) Clearance for New Cyb .. Multileaf Collimation with Non-Isocentric Robotic

[ Thu, Nov 01st 2012 ] - Market Wire

30 a.m. ET November 8, 2012 to Discuss Third Quarter 2012 Results

[ Thu, Nov 01st 2012 ] - Market Wire

AcelRx Pharmaceuticals to Hold Third Quarter 2012 .. s Conference Call and Webcast on November 6, 2012

[ Thu, Nov 01st 2012 ] - Market Wire

Neovasc Inc. Finalizes US $4.6 Million Agreement .. ts to In-House Manufacture of Xenosure Surgical P

[ Thu, Nov 01st 2012 ] - Market Wire

Digirad Corporation Reports 2012 Third Quarter and Nine-Month Financial Results

Wed, October 31, 2012

[ Wed, Oct 31st 2012 ] - Market Wire

Watson Announces Global Generics Management Team

[ Wed, Oct 31st 2012 ] - Market Wire

Watson Announces New Name -- Actavis -- for Global Operations

[ Wed, Oct 31st 2012 ] - Market Wire

Watson Completes Actavis Acquisition

[ Wed, Oct 31st 2012 ] - Market Wire

Sanofi and Regeneron Announce Publication of Phas .. rol-Lowering PCSK9 Antibody in the New England Jo

[ Wed, Oct 31st 2012 ] - Market Wire

Arena Pharmaceuticals to Host Corporate Update an .. onference Call and Webcast on Tuesday, November 6

OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference

_{//health-fitness.news-articles.net/content/2012/ .. -to-present-at-upcoming-investor-conference.html}
^{Published in Health and Fitness on Friday, November 9th 2012 at 4:00 GMT by Market Wire}

OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference

BOTHELL, WA and VANCOUVER, BC, Nov. 9, 2012 /PRNewswire/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: [ OGXI ]) announced today that Scott Cormack, President and Chief Executive Officer, will provide a corporate presentation at the Lazard Capital Markets Healthcare Conference on Wednesday, November 14, 2012 at 10:00 a.m. ET at the Pierre Hotel in New York City.

Live audio webcasts can be accessed through the Investor Relations page of the OncoGenex website at [ www.oncogenex.com ]. Webcast replays will be archived for 60 days.

About OncoGenex
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) have entered a global collaboration and license agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer. OGX-427 is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development. More information is available at [ www.OncoGenex.com ]

SOURCE OncoGenex Pharmaceuticals, Inc.

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire